Author/Creator: Fuso, L. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Fuso, L.

1. 00067 HOW PRETREATMENT SERUM HEMOGLOBIN LEVEL CAN BE A PREDICTIVE FACTOR OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CERVICAL CARCINOMA. (1st September 2005)

Authors:: Mazzola, S.; Fuso, L.; Marocco, F.; Ferrero, A.; Carus, A. Peroglio; Zola, P.
Journal:: International journal of gynecological cancer
Issue:: Volume 15(2005)Supplement 2
Page Start:: 69
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Diagnostic accuracy and cost‐effectiveness of different strategies to triage women with adnexal masses: a prospective study. (5th September 2017)

Authors:: Piovano, E.; Cavallero, C.; Fuso, L.; Viora, E.; Ferrero, A.; Gregori, G.; Grillo, C.; Macchi, C.; Mengozzi, G.; Mitidieri, M.; Pagano, E.; Zola, P.
Journal:: Ultrasound in obstetrics & gynecology
Issue:: Volume 50:Number 3(2017)
Page Start:: 395
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence. (October 2018)

Authors:: Biglia, N.; Bounous, V.E.; Gallo, M.; Fuso, L.; Sgro, L.G.; Maggiorotto, F.; Ponzone, R.
Journal:: Breast
Issue:: Volume 41(2018)
Page Start:: 8
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Follow-up strategies in gynecological oncology: searching appropriateness. Issue 6 (1st October 2007)

Authors:: Zola, P.; Fuso, L.; Mazzola, S.; Gadducci, A.; Landoni, F.; Maggino, T.; Sartori, E.
Journal:: International journal of gynecological cancer
Issue:: Volume 17:Issue 6(2007)
Page Start:: 1186
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients. (1st January 2006)

Authors:: Fuso, L.; Amant, F.; Neven, P.; Berteloot, P.; Vergote, I.
Journal:: International journal of gynecological cancer
Issue:: Volume 16(2006)Supplement 1
Page Start:: 60
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Influence of body mass index on aromatase inhibitors' efficacy in breast cancer patients. (March 2017)

Authors:: Liberale, V.; Romenskaya, T.; Fuso, L.; Sgro, L.G.; Ottino, L.; Bounous, V.E.; D'Alonzo, M.; Biglia, N.
Journal:: Breast
Issue:: Volume 32(2017)Supplement 1
Page Start:: S89
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. LAPAROSCOPY AS PRIMARY TREATMENT FOR WOMEN WITH EARLY STAGE ENDOMETRIAL CARCINOMA. Issue 1 (1st March 2003)

Authors:: Volpi, E.; Jacomuzzi, M. E.; Fuso, L.; Magistris, A.; Carus, A. Peroglio; Martra, F.; Sismondi, P.
Journal:: International journal of gynecological cancer
Issue:: Volume 13:Issue 1(2003) Supplement
Page Start:: 74
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗